ClinicalTrials.gov
public full text
Public Domain
Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults
Tranexamic acid (TXA) reduces head injury deaths. The CRASH-4 trial aims to assess the effects of early intramuscular TXA on intracranial haemorrhage, disability, death, and dementia in older adults with symptomatic mild head injury
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evidence reviews for tranexamic acid: Head injury: assessment and early management: Evidence review A#2216
- Correspondence - Tranexamic acid for traumatic brain injury#6885
- Seizures and Traumatic Brain Injury Rehabilitation#847748
- Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis#827075
- Comparing Injury Volume and Epilepsy Outcomes for Traumatic Brain Injury (TBI) Patients#989837
Record · ID 1322166
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive